My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 121

    1.

    Regulation of MYCN expression in human neuroblastoma cells.

    Jacobs JF, van Bokhoven H, van Leeuwen FN, Hulsbergen-van de Kaa CA, de Vries IJ, Adema GJ, Hoogerbrugge PM, de Brouwer AP.

    BMC Cancer. 2009 Jul 18;9:239.PMID: 19615087 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features.

    Tajiri T, Liu X, Thompson PM, Tanaka S, Suita S, Zhao H, Maris JM, Prendergast GC, Hogarty MD.

    Clin Cancer Res. 2003 Aug 15;9(9):3345-55.PMID: 12960121 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Relationship of DDX1 and NAG gene amplification/overexpression to the prognosis of patients with MYCN-amplified neuroblastoma.

    Kaneko S, Ohira M, Nakamura Y, Isogai E, Nakagawara A, Kaneko M.

    J Cancer Res Clin Oncol. 2007 Mar;133(3):185-92. Epub 2006 Oct 7.PMID: 17028906 [PubMed - indexed for MEDLINE]Related articles

    4.

    Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma.

    Manohar CF, Salwen HR, Brodeur GM, Cohn SL.

    Genes Chromosomes Cancer. 1995 Nov;14(3):196-203.PMID: 8589036 [PubMed - indexed for MEDLINE]Related articles

    5.

    ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.

    Wang Q, Hii G, Shusterman S, Mosse Y, Winter CL, Guo C, Zhao H, Rappaport E, Hogarty MD, Maris JM.

    Cancer Res. 2003 Apr 1;63(7):1631-5.PMID: 12670915 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    [Study on MYCN gene amplification and CD44 expression in neuroblastoma]

    Hu HL, He LJ.

    Zhonghua Bing Li Xue Za Zhi. 2004 Aug;33(4):332-6. Chinese. PMID: 15363318 [PubMed - indexed for MEDLINE]Related articles

    7.

    p73alpha isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cells.

    Horvilleur E, Bauer M, Goldschneider D, Mergui X, de la Motte A, Bénard J, Douc-Rasy S, Cappellen D.

    Nucleic Acids Res. 2008 Aug;36(13):4222-32. Epub 2008 Jun 25.PMID: 18583365 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Clinical significance of a highly sensitive analysis for gene dosage and the expression level of MYCN in neuroblastoma.

    Tanaka S, Tajiri T, Noguchi S, Shono K, Ihara K, Hara T, Suita S.

    J Pediatr Surg. 2004 Jan;39(1):63-8.PMID: 14694373 [PubMed - indexed for MEDLINE]Related articles

    9.

    MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCN.

    Cohn SL, London WB, Huang D, Katzenstein HM, Salwen HR, Reinhart T, Madafiglio J, Marshall GM, Norris MD, Haber M.

    J Clin Oncol. 2000 Nov 1;18(21):3604-13.PMID: 11054433 [PubMed - indexed for MEDLINE]Related articles

    10.

    Prediction of MYCN amplification in neuroblastoma using serum DNA and real-time quantitative polymerase chain reaction.

    Gotoh T, Hosoi H, Iehara T, Kuwahara Y, Osone S, Tsuchiya K, Ohira M, Nakagawara A, Kuroda H, Sugimoto T.

    J Clin Oncol. 2005 Aug 1;23(22):5205-10.PMID: 16051962 [PubMed - indexed for MEDLINE]Related articles

    11.

    Clinical implications of a slight increase in the gene dosage of MYCN in neuroblastoma determined using quantitative PCR.

    Souzaki R, Tajiri T, Higashi M, Kinoshita Y, Tanaka S, Kohashi K, Tsuneyoshi M, Taguchi T.

    Pediatr Surg Int. 2008 Oct;24(10):1095-100.PMID: 18726105 [PubMed - indexed for MEDLINE]Related articles

    12.

    Pilot study to evaluate MYCN expression as a neuroblastoma cell marker to detect minimal residual disease by RT-PCR.

    Wagner LM, Burger RA, Guichard SM, Raimondi SC, Santana VM, Furman WL, Barnette P, Danks MK.

    J Pediatr Hematol Oncol. 2006 Oct;28(10):635-41.PMID: 17023822 [PubMed - indexed for MEDLINE]Related articles

    13.

    Significance of survivin mRNA expression in prognosis of neuroblastoma.

    Ito R, Asami S, Motohashi S, Ootsuka S, Yamaguchi Y, Chin M, Shichino H, Yoshida Y, Nemoto N, Mugishima H, Suzuki T.

    Biol Pharm Bull. 2005 Apr;28(4):565-8.PMID: 15802787 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma.

    Chen QR, Bilke S, Wei JS, Whiteford CC, Cenacchi N, Krasnoselsky AL, Greer BT, Son CG, Westermann F, Berthold F, Schwab M, Catchpoole D, Khan J.

    BMC Genomics. 2004 Sep 20;5(1):70.PMID: 15380028 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Expression of inhibitor-of-apoptosis protein (IAP) livin by neuroblastoma cells: correlation with prognostic factors and outcome.

    Kim DK, Alvarado CS, Abramowsky CR, Gu L, Zhou M, Soe MM, Sullivan K, George B, Schemankewitz E, Findley HW.

    Pediatr Dev Pathol. 2005 Nov-Dec;8(6):621-9. Epub 2005 Nov 18.PMID: 16328668 [PubMed - indexed for MEDLINE]Related articles

    16.

    In vivo angiogenic activity of neuroblastoma correlates with MYCN oncogene overexpression.

    Ribatti D, Raffaghello L, Pastorino F, Nico B, Brignole C, Vacca A, Ponzoni M.

    Int J Cancer. 2002 Dec 1;102(4):351-4.PMID: 12402304 [PubMed - indexed for MEDLINE]Related articles

    17.

    Coamplification of DDX1 correlates with an improved survival probability in children with MYCN-amplified human neuroblastoma.

    Weber A, Imisch P, Bergmann E, Christiansen H.

    J Clin Oncol. 2004 Jul 1;22(13):2681-90.PMID: 15226335 [PubMed - indexed for MEDLINE]Related articles

    18.

    Association among EPHB2, TrkA, and MYCN expression in low-stage neuroblastomas.

    Tang XX, Evans AE, Zhao H, Cnaan A, Brodeur GM, Ikegaki N.

    Med Pediatr Oncol. 2001 Jan;36(1):80-2.PMID: 11464911 [PubMed - indexed for MEDLINE]Related articles

    19.

    The MYCN enigma: significance of MYCN expression in neuroblastoma.

    Tang XX, Zhao H, Kung B, Kim DY, Hicks SL, Cohn SL, Cheung NK, Seeger RC, Evans AE, Ikegaki N.

    Cancer Res. 2006 Mar 1;66(5):2826-33.PMID: 16510605 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Use of RNA interference to elucidate the effect of MYCN on cell cycle in neuroblastoma.

    Woo CW, Tan F, Cassano H, Lee J, Lee KC, Thiele CJ.

    Pediatr Blood Cancer. 2008 Feb;50(2):208-12.PMID: 17420990 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity